Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov-Dec;47(5):360-7.
doi: 10.1080/02791072.2015.1096434. Epub 2015 Nov 23.

Experiences of Kratom Users: A Qualitative Analysis

Affiliations

Experiences of Kratom Users: A Qualitative Analysis

Marc T Swogger et al. J Psychoactive Drugs. 2015 Nov-Dec.

Abstract

Kratom (Mitragyna speciosa) is a psychoactive plant that has been used since at least 1836 in folk medicine in Southeast Asian countries. More recently, kratom has become widely available in the West and is used for both recreational and medicinal purposes. There has, however, been little scientific research into the short- and long-term effects of kratom in humans, and much of the information available is anecdotal. To supplement the increasing scientific understanding of kratom's pharmacology and research into its effects in animals, we report the results of a qualitative analysis of first-hand descriptions of human kratom use that were submitted to, and published by, a psychoactive substance information website (Erowid.org). Themes that emerged from these experience reports indicate that kratom may be useful for analgesia, mood elevation, anxiety reduction, and may aid opioid withdrawal management. Negative response themes also emerged, indicating potential problems and unfavorable "side" effects, especially stomach upset and vomiting. Based on our analyses, we present preliminary hypotheses for future examination in controlled, quantitative studies of kratom.

Keywords: Mitragyna speciosa; analgesia; kratom; social anxiety; substance use.

PubMed Disclaimer

References

    1. Azizi J, Ismail S, Mordi MN, Ramanathan S, Said MIM, and Mansor SM. 2010. In vitro and in vivo effects of three different Mitragyna speciosa korth leaf extracts on phase II drug metabolizing enzymes glutathione transferases (GSTS). Molecules 15:432–41. doi: 10.3390/molecules15010432. - DOI - PMC - PubMed
    1. Bachhuber MA, Saloner B, Cunningham CO, and Barry CL. 2014. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Internal Medicine 174:1668–73. doi: 10.1001/jamainternmed.2014.4005. - DOI - PMC - PubMed
    1. Backstrom BG, Classon G, Lowenhielm P, and Thelander G. 2010. Krypton–ny, dodlig Internetdrog. Sedan oktober 2009 har nio unga personer dott i Sverige. [Krypton–new, deadly Internet drug. Since October 2009 nine young persons have died in Sweden]. Lakartidningen 107:3196–97. - PubMed
    1. Barratt MJ, Allen M, and Lenton S. 2014. “PMA sounds fun”: Negotiating drug discourses online. Substance Use & Misuse 49:987–98. doi: 10.3109/10826084.2013.852584. - DOI - PubMed
    1. Botpiboon O, Prutipanlai S, Janchawee B, and Thainchaiwattana S. 2007. Effects of caffeine and codeine on antinociceptive activity of alkaloid extract from leaves of kratom (Mitragyna speciosa korth). Paper presented at the 35th Congress on Science and Technology of Thailand, The Tide Resort (Bangsaen Beach), Chonburi, Thailand, October 15–17, 2009.

LinkOut - more resources